Source: International Congress 2017 – ILDs: clinical problems
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Sterclova (Praha, Czech Republic). Interstitial pneumonia vs. hypersensitivity pneumonitis with autoimmune features. 867

Member's Comments

No comment yet.

Related content which might interest you: Interstitial pneumonia with autoimmune features Source: Eur Respir Monogr 2019; 86: 140-152 Year: 2019 Interstitial pneumonia with autoimmune features Source: Guideline 2015 Year: 2015 Usual interstitial pneumonia pattern in chronic hypersensitivity pneumonitis Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Chronic hypersensitivity pneumonitis and its differential diagnosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=189 Year: 2007 Characterisation of patients with interstitial pneumonia with autoimmune features Source: Eur Respir J 2016; 47:1767-1775 Year: 2016 Haemorrhagic hypersensitivity pneumonitis due to naphthylene-1,5-diisocyanate Source: Eur Respir J 2002; 19: 377-380 Year: 2002 Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis Source: Virtual Congress 2020 – Diagnosis and management of chronic fibrotic hypersensitivity pneumonitis Year: 2020 Chronic hypersensitivity pneumonitis with familial history of interstitial lung disease Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease Year: 2010 Idiopathic non-specific interstitial pneumonia (NSIP): is it an autoimmune clinical entity? Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases Year: 2007 Interstitial pneumonia with autoimmune features: a new classification still on the move Source: Eur Respir Rev, 27 (148) 180047; 10.1183/16000617.0047-2018 Year: 2018 Distinguishing fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis Source: International Congress 2019 – Lungs in the fog Year: 2019 Different characteristics and outcomes of acute exacerbation: comparison between interstitial pneumonia with autoimmune features and lone idiopathic interstitial pneumonia. Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Cyclophosphamide in steroid refractory unclassifiable idiopathic interstitial pneumonia and interstitial pneumonia with autoimmune features (IPAF) Source: Eur Respir J, 51 (4) 1702519; 10.1183/13993003.02519-2017 Year: 2018 Cyclophosphamide in steroid-refractory hypersensitivity pneumonitis and non-classifiable interstitial lung disease Source: International Congress 2017 – Novel and old entities Year: 2017 Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis Source: Eur Respir J 2001; 18: 43S-55S Year: 2001 Ciprofloxacin-induced acute interstitial pneumonitis Source: Eur Respir J 2004; 23: 172-174 Year: 2004 Clinical features of pulmonary aspergillosis in patients with chronic fibrosing interstitial pneumonia Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Bosutinib-related pneumonitis Source: Eur Respir J, 50 (3) 1700930; 10.1183/13993003.00930-2017 Year: 2017 Idelalisib-related pneumonitis Source: Eur Respir J 2016; 47: 1280-1283 Year: 2016 Pembrolizumab-induced pneumonitis Source: ERJ Open Res, 3 (2) 00081-2016; 10.1183/23120541.00081-2016 Year: 2017